Skip to main content
. 2019 Apr 9;17(6):5693–5698. doi: 10.3892/ol.2019.10233

Figure 2.

Figure 2.

miR-152 could differentiate patients with CIN from patients with cervical cancer from healthy controls. ROC curves indicating that (A) the peripheral blood levels of miR-152 may differentiate patients with CIN from healthy controls and (B) the peripheral blood levels of miR-152 may differentiate patients with cervical cancer from healthy controls. miR-152, microRNA-152; ROC, receiver operating characteristic; CIN, cervical intraepithelial neoplasia.